Implicity ILR ECG Analyzer vs IM007

When choosing between Implicity’s ILR ECG Analyzer and IM007, physicians should consider their primary focus in cardiac remote monitoring. The Implicity ILR ECG Analyzer is specifically designed for optimizing the analysis of data from implantable loop recorders (ILRs), particularly Medtronic devices. It excels at reducing false positives in ILR ECG recordings by 79% while maintaining 99% sensitivity, thereby streamlining arrhythmia detection and reducing the burden of reviewing non-actionable events.

The IM007, on the other hand, is a broader, unified AI-powered platform for remote cardiac monitoring that aggregates data from all major cardiac implantable electronic devices (CIEDs), including those from Abbott, Biotronik, Boston Scientific, Medtronic, and MicroPort. While it incorporates the ILR ECG Analyzer’s capabilities for reducing false positives, IM007 also offers additional features such as SignalHF, an FDA-cleared predictive AI for heart failure hospitalization risk, and comprehensive EHR integration.

The key practical difference lies in their scope: the ILR ECG Analyzer is a specialized tool for ILR data, whereas IM007 is a comprehensive platform for managing a wider range of CIED data and offering predictive analytics. Physicians whose practice primarily involves managing patients with Medtronic ILRs and who seek to optimize arrhythmia detection workflow might find the dedicated ILR ECG Analyzer sufficient. However, those who manage a diverse patient population with various CIEDs and require advanced features like heart failure risk prediction and extensive EHR integration would benefit more from the broader capabilities of the IM007 platform.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist